Deletion of IP6K1 in mice accelerates tumor growth by dysregulating the tumor-immune microenvironment

References

• Ahn H, Roh JS, Lee S, Beon J, Lee B, Sohn DH, Kim S. 2021. Myeloid IPMK promotes the resolution of serum transfer-induced arthritis in mice. Animal Cells Syst (Seoul). 25(4):219–226. doi:https://doi.org/10.1080/19768354.2021.1952305.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Juluri KR, Resnick AC, Snyder SH. 2008. Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci U S A. 105(7):2349–2353. doi:https://doi.org/10.1073/pnas.0712227105.
   PubMedGoogle Scholar
• Chakraborty A. 2018. The inositol pyrophosphate pathway in health and diseases. Biol Rev. 93(2):1203–1227. doi:https://doi.org/10.1111/brv.12392.
   PubMedGoogle Scholar
• Chakraborty A, Kim S, Snyder SH. 2011. Inositol pyrophosphates as mammalian cell signals. Sci Signal. 4(188):1–12. doi:https://doi.org/10.1126/scisignal.2001958.
   Web of Science ®Google Scholar
• Chakraborty A, Koldobskiy MA, Bello NT, Maxwell M, Potter JJ, Juluri KR, Maag D, Kim S, Huang AS, Dailey MJ, et al. 2010. Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell. 143(6):897–910. doi:https://doi.org/10.1016/j.cell.2010.11.032.
   PubMed Web of Science ®Google Scholar
• Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. 2018. Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy. Front Immunol. 9(JAN):14.
   PubMedGoogle Scholar
• Farhood B, Najafi M, Mortezaee K. 2019. CD8 + cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol. 234(6):8509–8521. doi:https://doi.org/10.1002/jcp.27782.
   PubMed Web of Science ®Google Scholar
• Fu C, Xu J, Cheng W, Rojas T, Chin AC, Snowman AM, Harraz MM, Snyder SH. 2017. Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase. Proc Natl Acad Sci U S A. 114(8):2036–2041. doi:https://doi.org/10.1073/pnas.1700165114.
   PubMedGoogle Scholar
• Gardner A, de Mingo Pulido Á, Ruffell B. 2020. Dendritic cells and their role in immunotherapy. Front Immunol. 11(May):1–14.
   PubMedGoogle Scholar
• Garris CS, Luke JJ. 2020. Dendritic cells, the T-cell-inflamed tumor microenvironment, and immunotherapy treatment response. Clin Cancer Res. 26(15):3901–3907. doi:https://doi.org/10.1158/1078-0432.CCR-19-1321.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Shukla D, Suman K, Jyothi Lakshmi B, Manorama R, Kumar S, Bhandari R. 2013. Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels. Blood. 122(8):1478–1486. doi:https://doi.org/10.1182/blood-2013-01-481549.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell [Internet]. 21(3):309–322. doi:https://doi.org/10.1016/j.ccr.2012.02.022.
   PubMed Web of Science ®Google Scholar
• Jadav RS, Kumar D, Buwa N, Ganguli S, Thampatty SR, Balasubramanian N, Bhandari R. 2016. Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice. Cell Signal [Internet]. 28(8):1124–1136. doi:https://doi.org/10.1016/j.cellsig.2016.04.011.
   PubMedGoogle Scholar
• Kenny PA, Lee GY, Bissell MJ. 2007. Targeting the tumor microenvironment. Front Biosci. 12(9):3468–3474. doi:https://doi.org/10.2741/2327.
   PubMedGoogle Scholar
• Kim CW, Kim KD, Lee HK. 2021. The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets. BMB Rep. 54(1):31–43. doi:https://doi.org/10.5483/BMBRep.2021.54.1.224.
   PubMed Web of Science ®Google Scholar
• Kim E, Beon J, Lee S, Park SJ, Ahn H, Kim MG, Park JE, Kim W, Yuk JM, Kang SJ, et al. 2017. Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6. Sci Adv. 3(4):1–14.
   Google Scholar
• Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. 2020. The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol. 11(May):1–22.
   PubMedGoogle Scholar
• Landrier JF, Derghal A, Mounien L. 2019. MicroRNAs in obesity and related metabolic disorders. Cells. 8(8). doi:https://doi.org/10.3390/cells8080859.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim W, Kang H-G, Kim W-J, Lee SC, Kim S-J. 2020. Geranium thunbergii extract-induced G1 phase cell cycle arrest and apoptosis in gastric cancer cells. Animal Cells Syst (Seoul). 24(1):26–33. doi:https://doi.org/10.1080/19768354.2019.1699161.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim MG, Ahn H, Kim S. 2020. Inositol pyrophosphates: signaling molecules with pleiotropic actions in mammals. Molecules. 25(9):7–9.
   Google Scholar
• Lee T, Lee J, Won J, Yang Y, Park SJ, Lee S, Pavlovic I, Kong B, Jho YS, Jessen HJ, et al. 2017. Erratum: Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis (Proceedings of the National Academy of Sciences of the United States of America (2016) 113 (8314–8319) doi:https://doi.org/10.1073/pnas.1521600113). Proc Natl Acad Sci U S A. 114(33):E7030. doi:https://doi.org/10.1073/pnas.1712781114.
   PubMedGoogle Scholar
• Murciano-Goroff YR, Warner AB, Wolchok JD. 2020. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res [Internet]. 30(6):507–519. doi:https://doi.org/10.1038/s41422-020-0337-2.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee S, Park SE, Kim S. 2018. Inositol pyrophosphates as multifaceted metabolites in the regulation of mammalian signaling networks. Animal Cells Syst (Seoul) [Internet]. 22(1):1–6. https://doi.org/https://doi.org/10.1080/19768354.2017.1408684.
   Web of Science ®Google Scholar
• Park SJ, Park H, Kim MG, Zhang S, Park SE, Kim S, Chung CH. 2020. Inositol pyrophosphate metabolism regulates presynaptic vesicle cycling at central synapses. iScience [Internet]. 23(4):101000. https://doi.org/https://doi.org/10.1016/j.isci.2020.101000.
   PubMedGoogle Scholar
• Prasad A, Jia Y, Chakraborty A, Li Y, Jain SK, Zhong J, Roy SG, Loison F, Mondal S, Sakai J, et al. 2011. Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. Nat Immunol. 12(8):752–760. doi:https://doi.org/10.1038/ni.2052.
   PubMedGoogle Scholar
• Rao F, Xu J, Khan AB, Gadalla MM, Cha JY, Xu R, Tyagi R, Dang Y, Chakraborty A, Snyder SH. 2014. Inositol hexakisphosphate kinase-1 mediates assembly/disassembly of the crl4-signalosome complex to regulate DNA repair and cell death. Proc Natl Acad Sci U S A. 111(45):16005–16010. doi:https://doi.org/10.1073/pnas.1417900111.
   PubMedGoogle Scholar
• Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH. 1999. Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol. 9(22):1323–1326. doi:https://doi.org/10.1016/S0960-9822(00)80055-X.
   PubMedGoogle Scholar
• Saiardi A, Nagata E, Luo HR, Snowman AM, Snyder SH. 2001. Identification and Characterization of a Novel Inositol Hexakisphosphate Kinase. J Biol Chem [Internet]. 276(42):39179–39185. doi:https://doi.org/10.1074/jbc.M106842200.
   PubMedGoogle Scholar
• Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. 2020. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol [Internet]. 20(1):7–24. doi:https://doi.org/10.1038/s41577-019-0210-z.
   PubMed Web of Science ®Google Scholar
• Wylie B, Macri C, Mintern JD, Waithman J. 2019. Dendritic cells and cancer: from biology to therapeutic intervention. Cancers (Basel. 11(4):1–21. doi:https://doi.org/10.3390/cancers11040521.
   Google Scholar
• Xu J, Fu C, Cha JY, Gadalla MM, Xu R, Barrow JC, Snyder SH. 2020. Erratum: inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1 (Proceedings of the National Academy of Sciences of the United States of America (2015) 112 (1773–1778) doi:https://doi.org/10.1073/pnas.1424642112). Proc Natl Acad Sci U S A. 117(45):28526–28527. doi:https://doi.org/10.1073/pnas.2019638117.
   PubMedGoogle Scholar
• Yang AY, Choi EB, So Park M, Kim SK, Park MS, Kim MY. 2021. PARP1 and PRC2 double deficiency promotes BRCA-proficient breast cancer growth by modification of the tumor microenvironment. FEBS J. 288(9):2888–2910. doi:https://doi.org/10.1111/febs.15636.
   PubMedGoogle Scholar
• Zamora AE, Crawford JC, Thomas PG. 2018. Hitting the target: how t cells detect and eliminate tumors. J Immunol. 200(2):392–399. doi:https://doi.org/10.4049/jimmunol.1701413.
   PubMed Web of Science ®Google Scholar